Cancer Support Group

Thursday, Apr 15th

Last update:06:42:40 AM GMT

Home News and Update Year 2010 Scientists working on a new cancer drug - Times of India

Scientists working on a new cancer drug - Times of India

Australian scientists are working on developing a new cancer drug that could also have fewer side effects such as hair loss and ulcers.

According to Herald Sun , the drug, VGX-100, which works by cutting blood supply to tumours, may provide the ‘missing link" in the battle to cure cancer.

It could also have fewer side effects than existing treatments and offers hope to cancer patients who don't respond to standard medicines. The drug has been tested on mice with prostate, pancreatic and brain cancers, and human trials could begin as early as next year.

Melbourne-based Circadian Technologies presented its findings at the American Association of Cancer Research annual meeting.

Senior author of the study Megan Baldwin said there was evidence in some cases VGX-100 may work better than existing anti-cancer drug Avastin.. It may also be more effective than Avastin - about half of the 500,000 patients treated with it worldwide did not respond, Baldwin said adding VGX-100 was one of a new breed of biological-based drugs that were more specific and safer to use, causing fewer side effects such as hair loss and ulcers.

Walter and Eliza Hall Institute of Medical Research oncologist Clare Scott said Avastin combined with chemotherapy was not as good a treatment as doctors would like it to be.
She said VGX-100 - used with Avastin and chemotherapy - could be the "missing link" in attacking a tumour's blood supply.

Royal Melbourne Hospital oncologist Jayesh Desai said the find was significant because the drug attacked a different protein from existing treatments.

Follow us on Twitter for more stories

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion
Manthan Award

Link to Aarogya

aarogya logo